Guido Leoni

Company: Nouscom Srl

Job title: Lead of Bioinformatic Team

Seminars:

Assessing Immunogenicity & Clinical Activity of Neoantigen Vaccine to Design Successful Vaccines 9:30 am

How to predict immunogenicity of antigens by reviewing factors such as the antigen’s chemical properties, its ability to bind to MHC molecules, and its presentation to T cells Reviewing the available clinical or pre-clinical data to show the advances in neoantigen vaccines vs traditional vaccine and mRNA vaccines Highlighting that the neoantigen vaccine personalized approach…Read more

day: Pre-Conference Focus Day

Fireside Chat: The Future Treatment Landscape for Neoantigen Vaccines
Moderators: Kevin Sun, Guido Leoni 3:30 pm

Focusing on how neoantigen vaccines offer a promising solution for personalized and effective therapies Highlighting some of the latest research findings in this field, which have shown that neoantigen vaccines can induce potent and durable immune responses against cancer cells Evaluating how neoantigen vaccines have the potential to improve the outcome and quality of life…Read more

day: Pre-Conference Focus Day